Cytokinetics
Rudy Nurmin is a finance professional with extensive experience in commercial finance and analysis. Currently serving as Senior Manager of Commercial Finance at Cytokinetics since September 2021, Rudy has held key positions including Group Commercial Manager at REA Group Asia and Co-Founder of Jupigo. Previous roles include Sales Operations Business Analyst at New Relic, Inc., and Sr. Financial Analyst at Recommind, Informatica, Wilson Sonsini Goodrich and Rosati, and Adaptec, where expertise in financial analysis has been honed over years. Rudy holds a BSBA in Finance from The Ohio State University Fisher College of Business.
This person is not in any teams
Cytokinetics
15 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.